The FDA defines nanotechnology based on two main criteria: the size range of the materials (approximately 1 to 100 nanometers) and the unique properties that arise when materials are engineered at this scale. These properties can differ significantly from those of larger-scale materials, affecting their biological, chemical, and physical behaviors.
